Hepatitis B Vaccination Guidelines
Vaccination Approach
- The American College of Gastroenterology recommends universal vaccination for all adults aged 19-59 years, regardless of risk factors 1
- The Centers for Disease Control and Prevention recommends initiating a complete Hepatitis B vaccine series immediately for previously unvaccinated patients 1, 2
- Multiple vaccine options are available with different schedules, including HEPLISAV-B, ENGERIX-B, Recombivax HB, Twinrix, and PreHevbrio 1
Booster Dose Approach
- The American College of Gastroenterology recommends administering a single challenge/booster dose first, rather than restarting the entire series, for previously vaccinated patients with non-reactive antibodies 1, 3
- Test anti-HBs levels 4-8 weeks after the challenge dose to determine if further doses are needed 1
- If anti-HBs ≥10 mIU/mL after the booster, no further doses are needed, indicating immunologic memory 1, 3
Special Populations
- The Infectious Diseases Society of America recommends higher doses and more intensive monitoring for immunocompromised patients, including hemodialysis patients ≥20 years 4, 5
- The Centers for Disease Control and Prevention recommends annual anti-HBs testing for immunocompromised persons with ongoing exposure risk 2
- All adult IBD patients should be evaluated for latent HBV and vaccinated if non-immune due to 5% mortality risk from HBV reactivation during immunosuppression 1
Timing Considerations
- The Centers for Disease Control and Prevention recommends not delaying vaccination while waiting for serologic test results in individuals at risk of exposure 2, 3
- The first vaccine dose should be administered immediately after blood collection for testing 2